pharmaceuticals Despite generic threat, AbbVie (ABBV) remains a good long-term bet 3 years ago Biopharmaceutical firm AbbVie Inc. (NYSE: ABBV) is currently at a crucial juncture as it strives to overcome the threat from… ANGO Earnings: AngioDynamics swings to profit in Q4; revenues beat estimates 3 years ago AngioDynamics Inc. (NASDAQ: ANGO) on Tuesday reported a modest profit for the fourth quarter of 2022 compared to breakeven last… Abbott Laboratories (ABT) stock remains a compelling buy. Here’s why 3 years ago Like most healthcare-related businesses, Abbott Laboratories (NYSE: ABT) has been operating near full capacity for quite some time, with its… Walgreens Boots Alliance (WBA) Q3 profit drops on lower revenues; results beat 3 years ago Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday said its third-quarter revenues decreased. As a result, the healthcare service company's… ANGO Stock: Is it the right time to invest in AngioDynamics now? 3 years ago The performance of AngioDynamics, Inc. (NASDAQ: ANGO) has not been very impressive lately, despite being part of a rapidly growing… Stock Watch: Intuitive Surgical (ISRG) remains a good bet despite slowdown 3 years ago Intuitive Surgical, Inc. (NASDAQ: ISRG) is a market leader in the manufacturing and distribution of robotics-assisted surgical systems. The company’s products,… OptMed all set for $24 million IPO. Here’s what you need to know 3 years ago As IPO activity picks up momentum after a lull, technology and healthcare companies are dominating the scene as usual. The… Stock Watch: Key factors to consider before investing in Medtronic (MDT) 3 years ago More than two years into the pandemic, the healthcare sector remains under stress due to continuing COVID care activities and… MDT Earnings: Highlights of Medtronic’s Q4 2022 results 4 years ago Medical device maker Medtronic plc (NYSE: MDT) has reported an increase in profit for the fourth quarter of 2022, despite… Is Merck & Co. (MRK) a good investment after Q1 earnings? 4 years ago Merck & Co., Inc. (NYSE: MRK) is recovering from the virus-induced slowdown supported by stable demand across its product line… Trxade Health (MEDS) reports 6% growth in Q1 revenue; loss widens 4 years ago Pharmaceutical services company Trxade Health Inc (NASDAQ: MEDS) Monday reported a wider net loss for the first quarter of 2022 despite… Infographic: Highlights of Merck’s (MRK) Q1 2022 earnings 4 years ago Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than-expected earnings and revenues for the first quarter of 2022. The… Biogen’s (BIIB) long-term prospects look intact despite Alzheimer’s drug setback 4 years ago Biogen Inc. (NASDAQ: BIIB) is currently going through a difficult phase as the biotechnology firm’s main products face stiff competition… Stock Watch: Should you invest in Eli Lilly (LLY) after Q1 earnings? 4 years ago For Eli Lilly and Company (NYSE: LLY), 2021 was a fruitful year in terms of financial performance and product development.… Pfizer (PFE) anticipates an increase in orders for Paxlovid in coming months due to virus mutations 4 years ago Shares of Pfizer Inc. (NYSE: PFE) gained nearly 2% on Tuesday after the company delivered better-than-expected results for the first… Trxade Health Inc. (NASDAQ: MEDS) Q1 2022 Research Summary 4 years ago Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It… PFE Earnings: All you need to know about Pfizer’s Q1 2022 earnings results 4 years ago Pfizer Inc. (NYSE: PFE) reported first quarter 2022 earnings results today. Total revenues increased 77% year-over-year to $25.7 billion. Reported… Earnings: Highlights of Eli Lilly’s (LLY) Q1 2022 results 4 years ago Eli Lilly and Company (NYSE: LLY) has reported higher earnings and revenues for the first quarter of 2022. The numbers… Infographic: Highlights of Intuitive Surgical’s Q1 2022 earnings 4 years ago Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a decline in first-quarter earnings despite a double-digit growth in… Abbott Laboratories (ABT) Q1 2022 Infographic: Key financials and quarterly highlights 4 years ago Abbott (NYSE: ABT) today reported its first-quarter financial results for the period ended March 31, 2022. GAAP net earnings for… Johnson & Johnson (JNJ) reports Q1 2022 earnings 4 years ago Johnson & Johnson (NYSE: JNJ) reported first-quarter 2022 financial results before the regular market hours on Tuesday. The pharmaceutical giant… Next» « Previous